Who owns TENAYA THERAPEUTICS INC?
- Ticker: TNYA
- CUSIP Number: 87990a106
Tip: Access positions for across all investors
Analyze quarterly positions in Tenaya Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tenaya Therapeutics stock
Who bought or sold TENAYA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Column Group | 9.4M | $49M | 0% | Mar 2024 |
|
| Casdin Capital | 6.7M | $35M | 6% | Mar 2024 |
|
| RA Capital Management | 5.8M | $30M | 4% | Mar 2024 |
|
| BlackRock | 4.7M | $25M | 0% | Mar 2024 |
|
| T. Rowe Price Associates | 3.3M | $18M | -26% | Mar 2024 |
|
| FMR | 2.9M | $15M | -9% | Mar 2024 |
|
| Vanguard Group | 2.9M | $15M | 16% | Mar 2024 |
|
| Octagon Capital Advisors | 2.9M | $15M | 100% | Mar 2024 |
|
| Citadel Advisors | 2.3M | $12M | 13% | Mar 2024 |
|
| Integral Health Asset Management | 2.3M | $12M | 100% | Mar 2024 |
|
| VR Adviser | 1.6M | $8.1M | 100% | Mar 2024 |
|
| Geode Capital Management | 1.0M | $5.4M | 19% | Mar 2024 |
|
| Euclidean Capital | 1.0M | $5.3M | 0% | Mar 2024 |
|
| Alphabet | 916k | $4.8M | 0% | Mar 2024 |
|
| StepStone | 462k | $2.4M | 0% | Mar 2024 |
|
| Adage Capital Partners GP | 400k | $2.1M | 100% | Mar 2024 |
|
| Northern Trust | 398k | $2.1M | -7% | Mar 2024 |
|
| Millennium Management | 375k | $2.0M | -25% | Mar 2024 |
|
| Morgan Stanley | 316k | $1.7M | 276% | Mar 2024 |
|
| Nuveen Asset Management | 287k | $1.5M | 83% | Mar 2024 |
|
| Barclays | 274k | $1.4M | 313% | Mar 2024 |
|
| Bank of America Corporation | 226k | $1.2M | 52% | Mar 2024 |
|
| GSA Capital Partners | 224k | $1.2M | -52% | Mar 2024 |
|
| Bank of New York Mellon | 212k | $1.1M | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 193k | $1.0M | 6% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 190k | $994k | 100% | Mar 2024 |
|
| NEOS Investment Management | 183k | $959k | 100% | Mar 2024 |
|
| Acadian Asset Management | 179k | $936k | 72% | Mar 2024 |
|
| Jacobs Levy Equity Management | 169k | $882k | 91% | Mar 2024 |
|
| Charles Schwab Investment Management | 128k | $670k | 7% | Mar 2024 |
|
| Qube Research & Technologies | 127k | $665k | 16% | Mar 2024 |
|
| Soleus Capital Management | 122k | $639k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 115k | $600k | -21% | Mar 2024 |
|
| UBS Group | 110k | $576k | 145% | Mar 2024 |
|
| Two Sigma Investments | 108k | $567k | -43% | Mar 2024 |
|
| Goldman Sachs Group | 82k | $429k | 10% | Mar 2024 |
|
| American Century Companies | 80k | $418k | 122% | Mar 2024 |
|
| Dimensional Fund Advisors | 72k | $374k | -30% | Mar 2024 |
|
| Rhumbline Advisers | 71k | $370k | 3% | Mar 2024 |
|
| HighPoint Advisor | 70k | $342k | 100% | Dec 2023 |
|
| Susquehanna International | 69k | $361k | 100% | Mar 2024 |
|
| Squarepoint Ops | 65k | $339k | -55% | Mar 2024 |
|
| CornerCap Investment Counsel | 65k | $338k | -21% | Mar 2024 |
|
| Jane Street | 61k | $318k | 294% | Mar 2024 |
|
| Atticus Wealth Management | 57k | $296k | -18% | Mar 2024 |
|
| Woodline Partners | 56k | $293k | 100% | Mar 2024 |
|
| Denali Advisors | 43k | $227k | 0% | Mar 2024 |
|
| Alliancebernstein | 33k | $108k | 0% | Dec 2023 |
|
| Bailard | 33k | $172k | 0% | Mar 2024 |
|
| XTX Topco | 31k | $162k | -21% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 27k | $139k | 335% | Mar 2024 |
|
| American International | 23k | $75k | 1% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 20k | $107k | 41% | Mar 2024 |
|
| Jpmorgan Chase & Co | 19k | $99k | -37% | Mar 2024 |
|
| AQR Capital Management | 19k | $99k | -19% | Mar 2024 |
|
| Balyasny Asset Management | 18k | $96k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 16k | $86k | 15% | Mar 2024 |
|
| SG Americas Securities | 16k | $85k | -36% | Mar 2024 |
|
| Fox Run Management | 15k | $80k | 100% | Mar 2024 |
|
| Integrated Wealth Concepts | 15k | $79k | 50% | Mar 2024 |
|
| Ing Investment Management | 15k | $77k | -20% | Mar 2024 |
|
| Citigroup | 14k | $74k | 107% | Mar 2024 |
|
| Sei Investments | 11k | $59k | 100% | Mar 2024 |
|
| State of Wisconsin Investment Board | 11k | $56k | 100% | Mar 2024 |
|
| Jasper Ridge Partners | 10k | $54k | 0% | Mar 2024 |
|
| New York State Common Retirement Fund | 7.0k | $37k | 0% | Mar 2024 |
|
| Lazard Asset Management | 5.2k | $0 | 4% | Dec 2023 |
|
| California State Teachers Retirement System | 4.7k | $24k | -54% | Mar 2024 |
|
| Legal & General Group | 4.3k | $22k | 0% | Mar 2024 |
|
| Simplex Trading | 3.6k | $19k | -46% | Mar 2024 |
|
| Summit Investment Advisors | 3.3k | $17k | 0% | Mar 2024 |
|
| Tower Research Capital | 2.2k | $12k | -83% | Mar 2024 |
|
| Sandy Spring Bank | 2.0k | $11k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 1.1k | $0 | -93% | Mar 2024 |
|
| Amalgamated Bank | 979.00 | $5.0k | -72% | Mar 2024 |
|
| NISA Investment Advisors | 940.00 | $4.9k | 4% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 11.00 | $56.999800 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Tenaya Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| TD Asset Management | Dec 2023 | 220k | $713k |
| Wellington Management Company | Sep 2023 | 189k | $481k |
| D. E. Shaw & Co | Dec 2023 | 96k | $310k |
| Man Group | Dec 2023 | 39k | $125k |
| MetLife Investment Advisors | Sep 2023 | 25k | $64k |
| Marshall Wace | Dec 2023 | 19k | $61k |
| Redwood Wealth Management Group | Dec 2023 | 16k | $53k |
| Jump Financial | Sep 2023 | 15k | $37k |
| Florida State Board of Administration | Dec 2023 | 12k | $39k |
| Metropolitan Life Insurance Company | Sep 2023 | 2.6k | $6.6k |